Current Nanomaterials - Online First
Description text for Online First listing goes here...
-
-
Preparation and Characterization of a Coconut Oil Nanoemulsion for Ellagic Acid Encapsulation
Authors: Mahima, Kajal Tomer, Dharmendra Kumar and Pramod Kumar SharmaAvailable online: 29 October 2025More LessIntroductionEllagic acid, a BCS Class IV drug, suffers from poor solubility and permeability, limiting its therapeutic potential despite its wide pharmacological activities. This study aimed to develop a coconut oil-based Ellagic acid Nanoemulsion (CoEaNe) and evaluate its wound-healing efficacy.
MethodsCoEaNe was prepared using a modified ultrasonication process. Drug loading and entrapment efficiency were assessed via UV spectroscopy. Particle size and polydispersity index were measured with a zeta sizer, while particle morphology was examined using Field Emission Scanning Electron Microscopy (FESEM). In-vivo wound-healing activity was evaluated in the Albino Wistar rat model. Drug release kinetics were analyzed using various mathematical models.
ResultsThe nanoemulsion exhibited a Z-average of 137.9 nm with spherical morphology and demonstrated zero-order release kinetics. FESEM confirmed uniform spherical particles. In vivo, CoEaNe significantly enhanced wound healing, achieving complete closure of burn wounds compared to controls.
DiscussionThe research findings highlight the potential of CoEaNe as a promising drug delivery system for poorly soluble BCS Class IV drugs. The enhanced wound-healing effect may be attributed to the optimized particle size, sustained drug release, and improved entrapment efficiency.
ConclusionCoconut oil-based Ellagic acid Nanoemulsion (CoEaNe) has optimal and favorable physicochemical properties, efficient drug loading, and significant wound-healing efficacy in-vivo, suggesting its applicability as a novel carrier system for enhancing therapeutic outcomes of poorly soluble drugs.
-
-
-
-
-
Nanostructured Lipid Carriers: A Modern Approach to Optimizing Drug Delivery Systems
Authors: Komal Kashyap, Anjali Sharma, Vishnu Mittal and Hitesh MalhotraAvailable online: 22 August 2025More LessIntroductionNanostructured lipid carriers (NLCs) are emerging as advanced drug delivery systems with enhanced stability, controlled release, & improved bioavailability. These systems address limitations of traditional treatments, which often only alleviate symptoms and have side effects.
ObjectiveThe objective of this review is to explore advancements in NLC-based drug delivery, emphasizing their application in specific therapeutic areas, such as dermatology and cancer. It critically examines the potential of NLCs in overcoming the limitations of conventional treatments and compares them with solid lipid nanoparticles (SLNs). Key challenges are also discussed, including scale-up, regulatory considerations, and quality-by-design (QbD) approaches.
ResultsNLCs offer prolonged drug release, improved skin penetration, and enhanced bioavailability. Compared to conventional formulations, they also reduce adverse reactions and staining.
ConclusionNLCs, with their amphiphilic nature, represent a promising approach to topical drug delivery. They offer improved therapeutic outcomes & reduced side effects, and their potential in treating various diseases is promising.
-
-
-
Current Insights into Polymeric Nanocarriers for Delivery of Phytomedicines in Breast Cancer Therapy
Authors: Dipthi Shree, Chinam Niranjan Patra and Biswa Mohan SahooAvailable online: 23 July 2025More LessBackground and ObjectivesGlobally, breast cancer is the most prevalent malignant disease that affects females and is one of the major causes of cancer-related death for women. The first line of treatment for breast cancer consists of chemotherapy drugs combined with radiation and surgical intervention. However, because therapeutic agents do not yet reach the tumor site at sufficient concentrations, resulting in decreased pharmacokinetics and increased systemic adverse effects, pharmacotherapy has been altered. Chemotherapy for breast cancer is more effective and successful, and is less toxic when nanotechnology is employed. Many cancer forms develop multidrug resistance, which appears to be a critical factor in the failure of numerous chemotherapy treatment classes. Phytofabricated nanoparticles have been developed recently for targeted herbal drug administration, molecular biology screening of biological markers for malignancies, and in vivo cancer diagnostics. Phytofabricated polymeric nanoparticles are the most prominent and emerging nanocarriers that have gained much research attention in the field of novel drug delivery systems for real-time treatment of breast cancer (BC) tumors.
MethodsIn herbal drug delivery technologies, the advancement of phytopharmacological science has led to the elucidation of the composition of phytoconstituents and their biological activities. Nano-sized herbal medicines can overcome inadequate bioavailability, in vivo degradation and toxicity, uneven distribution, intestinal absorption, and a non-specific site of action. The combinatorial strategy of employing both nanotechnology and herbal medications allows for therapeutic potentiation, which reduces the required dose and undesirable harmful effects. In the present study, a comprehensive search utilizes databases such as Google Scholar, PubMed, Embase, Scopus, Web of Science, etc, to locate the original research papers. In addition, diligent work is done to gather and update the progress of novel polymer-based nanocarriers for treating BC in the form of tables.
ResultsResearchers have devised innovative approaches to create and cultivate nanomedicine specifically targeted at breast cancer to attain even greater gains in drug resistance reversal, antitumorigenicity, antimetastasis, and disease specificity. Nanoparticles' exceptionally high surface area-to-volume ratio makes it possible to modify their surface characteristics for better therapeutic outcomes, i.e., cancer targeting, enhanced endocytosis and transcytosis, and extended circulation. This allows for more effective entry into tumor sites, metastasis, and cancer cells. Additionally, co-administration of phytochemical combinations may enhance additive or synergistic anticancer effects.
ConclusionBreast cancer treatment with phytofabricated polymeric nanoparticles appears to be a potential avenue of research. Furthermore, the utilization of phytofabricated polymeric nanoparticles in conjunction with other loaded phytoconstituents or chemotherapeutics demonstrated encouraging outcomes in the treatment of BC. This article depicts a comprehensive new finding that formulation scientists are developing on phytochemical-based polymeric nanocarriers to pave the way for future pharmaceutical nanotechnology research.
-
-
-
Nanostructured Lipid Carriers: Enhancing Delivery of Poorly Soluble Drugs
Authors: Jeyaprabha Ponnusamy and Saravanan GopalAvailable online: 08 July 2025More LessNanostructured Lipid Carriers (NLCs) represent a cutting-edge advancement in drug delivery systems, designed to regulate the problems within conventional methods, particularly for poorly soluble drugs. These carriers are composed of a unique combination of solid and liquid lipids, forming a nanoscale matrix with improved stability, high drug-loading capacity, and controlled release properties. The objective of this study is to provide a comprehensive overview of NLCs and their potential to enhance the bioavailability of lipophilic and hydrophilic drugs. The review explores formulation techniques, including high-pressure homogenization, solvent emulsification, and microemulsion methods, highlighting their respective advantages and limitations. Key physicochemical properties of poorly soluble drugs, such as lipophilicity, crystallinity, and particle size, are discussed in relation to their compatibility with NLC systems. NLCs have significant potential as innovative drug delivery systems (DDS), particularly for pharmaceuticals with limited solubility. These nanoscale carriers effectively enhance drug solubility and bioavailability, protect drugs from degradation, facilitate controlled drug release, increase the drug disposition to the target organ, alter the pharmacokinetic characteristics of drug-loaded carriers, improve the therapeutic effect, decrease adverse side effects, and render them essential for pharmaceutical applications. Future perspectives emphasize the potential of NLCs in targeted drug delivery, personalized medicine, and combination therapies. The versatility and biocompatibility of NLCs make them a promising tool for addressing unmet medical needs. In conclusion, NLCs are poised to revolutionize modern pharmaceutical sciences by offering innovative solutions for drug delivery challenges, paving the way for more efficient and patient-centered curative approaches.
-
-
-
Electrical Behavior of Hydrogen-Induced Ultra Nano-Crystalline Diamond
Available online: 08 May 2025More LessIntroductionUltra-nanocrystalline diamond (UNCD) films, in the context of semiconductor and optoelectronic devices, represent a promising avenue for developing highly versatile and efficient technologies, leveraging their unique properties for versatile applications. The development of the unique morphology of UNCD films that could be used in versatile semiconductor/optoelectronics devices.
MethodsIn this study, a microwave plasma-enhanced chemical vapor deposition process was used to grow the UNCD thin films on silicon (100) substrates. The process was performed under various gas composition plasma atmospheres (H2, N2, Ar, and CH4) at a pressure of 120 Torr and the substrate temperature of 700°C after the creation of nano-sized diamond powder nucleation sites with a seeding density of ≈2×1012cm−2. Scanning electron microscopy images and X-ray diffraction techniques were used to study the surface morphology and crystal structure. For the Raman spectroscopy technique, four different excitation wavelengths of LASER light (448, 515, 647 and 785 nm) were used to confirm the formation of higher sp3-content, grain boundaries, structural diamond phase, and their dispersive/non-dispersive spectral components. C1s, O 1s, and N 1s X-ray photoelectron spectroscopy technique was employed to study the electronic/bonding structure of UNCD thin films, whereas ultra-violet (UV) photoemission technique was used to determine the work functions (Φ) and valence band maximum (VBM) of the UNCD films.
DiscussionStructural, electrical and electron field emission behaviours are strictly dependent on sp3-content presence in UNCD films structure.
ResultsIt was observed that the nano-structured UNCD film was dependent on the sp3-content presence in the film structure along with sp3-content and grain boundaries. The lowest Φ and VBM were obtained when the H2 introduction was 8 sccm and 5 sccm, respectively. Electron field emission results showed that the turn-on electric field (E0) is increased with an increase in the introduction of H2 flow rate during the preparation of UNCD films, resulting in an increase in the sp3-content in the film structure. The current-voltage (I-V) characteristics indicated that the conductivity of the films was low, with a current of ~10-10 A.
ConclusionThe prepared UNCD films were found suitable for the fabrication of transient testing, memristors, and other versatile semiconductor/optoelectronics devices.
-
-
-
Harnessing Nanoparticles for Effective Drug Delivery: A Comprehensive Review of Techniques and Therapeutic Applications
Authors: Rishika Chauhan and Anuj MalikAvailable online: 08 April 2025More LessThe current scenario of research is moving from the nanosized scale. This research posits that nanoparticle-based drug delivery systems can significantly enhance the therapeutic efficacy and bioavailability of poorly water-soluble drugs, thereby addressing critical challenges in the treatment of various diseases, including cancer, diabetes, and dermatological conditions.
In this study, a comprehensive review of various nanoformulation techniques was conducted, including nanoemulsions, lipid-based formulations, and polymeric nanoparticles. The study involved analyzing existing literature on the preparation methods, characterization, and optimization of nanoparticles for drug delivery. Additionally, case studies of approved and clinical trial drugs utilizing nanoparticle carriers were examined to assess their impact on bioavailability and therapeutic outcomes.
The findings indicate that nanoparticle formulations not only improve the solubility and stability of hydrophobic drugs but also facilitate targeted delivery, resulting in enhanced therapeutic effects and reduced side effects. Specific examples highlighted include the successful application of nanoparticles in gene therapy and oncology, demonstrating their potential to revolutionize treatment paradigms. By reviewing this article, the reviewer gets knowledge about the different array of tools, methods, and development achieved in the field of nanotechnology, and the article represents the sufficient information needed to achieve the best design of nanoformulation for drug development and bridge the gaps faced by researchers and the scientific community.
-
-
-
Quality by Design Approach for the Development of Polymeric Nanoparticles: A Focus on Capecitabine
Authors: Rakesh Chandra Parida, Devi Thamizhanban and Goutam Kumar JenaAvailable online: 04 April 2025More LessIntroduction/ObjectivePolymeric nanoparticles (PNPs) have emerged as promising drug delivery systems to overcome the limitations of conventional chemotherapeutics. Capecitabine, a prodrug of 5-fluorouracil (5-FU), is widely used in cancer therapy but suffers from poor bioavailability and systemic toxicity. The application of the Quality by Design (QbD) framework in PNP development provides a structured approach to address these challenges. This review examines the QbD principles in the formulation and optimization of capecitabine-loaded PNPs, focusing on strategies to enhance therapeutic efficacy and minimize adverse effects.
MethodsThe QbD approach encompasses defining a Quality Target Product Profile (QTPP), identifying Critical Quality Attributes (CQAs), and conducting risk assessments to pinpoint Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs). Techniques such as Design of Experiments (DoE) facilitate systematic optimization.
ResultsIncorporating QbD principles ensures the development of robust PNP formulations with improved encapsulation efficiency, controlled drug release, and targeted delivery. Studies highlight the use of biodegradable polymers like PLGA, chitosan, and PEG for superior biocompatibility and stability. Analytical methods validate the consistency and quality of the nanoparticles.
ConclusionThe QbD framework enables the rational design of capecitabine-loaded PNPs with enhanced bioavailability and reduced toxicity, contributing to safer and more effective cancer treatments. Future research should explore novel polymeric systems and advanced manufacturing technologies to expand the therapeutic potential of PNPs in oncology.
-
-
-
Comparative Therapeutic Efficacy of Lipid-Based Nanocarriers versus Traditional Treatments for Psoriasis: A Comprehensive Review
Authors: Shatrudhan Prajapati and Shikha YadavAvailable online: 12 February 2025More LessPsoriasis is a chronic inflammatory skin condition with complex autoimmune and genetic origins, affecting approximately 125 million people globally, with prevalence rates ranging from 0.9% in the U.S. to 8.5% in Norway. This disease places a substantial economic burden on healthcare systems, with the average annual treatment cost per individual in the U.S. estimated at $2,528. Existing therapies often fall short due to issues like limited drug penetration and adverse effects, leading to patient dissatisfaction and treatment discontinuation. This review examines advancements in lipid-based nanocarriers for topical psoriasis management, highlighting their potential to overcome these therapeutic barriers. Lipid-based nanocarriers, including liposomes, niosomes, and Nanostructured Lipid Carriers (NLCs), enhance drug stability, controlled release, and targeted delivery, which are pivotal in improving therapeutic outcomes. Innovations in combinatorial lipid-based therapies show promise in preclinical and clinical studies, supporting enhanced efficacy and improved quality of life for psoriasis patients. Future research should focus on optimizing these carriers for greater precision alongside rigorous clinical evaluations to validate their safety and impact.
-
-
-
Nanotubes and Nanodiamonds in 3D printing: Enhancing Mechanical and Biological Properties of Nanocomposites through Advanced Formulation Technologies
Authors: Chirag Jain, Teena Garg, Shikha Baghel Chauhan and Indu SinghAvailable online: 16 December 2024More LessAimWith the aim to improve the thermal and mechanical characteristics of nanocomposites for cutting-edge engineering applications, this work looks at how nanotubes and nanodiamonds can be integrated into 3D printing processes.
BackgroundThe performance of 3D-printed products has been greatly enhanced by the addition of nanomaterials like carbon nanotubes as well as nanodiamonds into polymer matrices. While nanodiamonds offer remarkable hardness and thermal stability, carbon nanotubes are widely recognized for their better electrical conductivity and bending strength. Their qualities make them the best options for raising the calibre of nanocomposites that are 3D printed.
ObjectiveThis paper looks at the effects of dispersion, functionalization, and synthesis of nanotubes and nanodiamonds on the mechanical and thermal properties of nanocomposites, taking into account the environmental impact, obstacles, and applications of these materials.
MethodsThe techniques for adding nanotubes and nanodiamonds to 3D printing formulations were the main topic of a thorough literature study. A number of important factors were examined, including stability, toughness, elasticity, and tensile strength. The influence of uniform particle spread on overall composite performance as well as developments in dispersion technologies were reviewed in the paper.
ResultsThe study found that the incorporation of nanotubes and nanodiamonds into 3D printing processes significantly improved the mechanical and biological properties of nanocomposites. These nanomaterials improved electrical conductivity and thermal stability, making them suitable for applications in electronics, aerospace, and biomedical fields. However, challenges such as high costs, ecological impacts, and long-term stability assessments remain.
ConclusionAlthough there is potential for next-generation materials with the incorporation of nanotubes along with nanodiamonds in 3D-printed nanocomposites, issues such as uniform nanoparticle dispersion still need to be resolved.
-
-
-
Green Synthesis Techniques for Sulphur Nanoparticles: Current Methods and Future Perspectives
Authors: Ajay Kumar Shukla and Manoj Kumar MishraAvailable online: 03 December 2024More LessIn recent years, cancer has emerged as a significant public health challenge, prompting extensive research into the development of innovative anticancer therapies capable of selectively inducing cell death or halting the proliferation of cancer cells. Harnessing the distinctive characteristics of nanomaterials, advancements in nanotechnology have played a pivotal role in the progression of nanomedicine for cancer treatment. Various nanomaterials, such as gold, silver, silica, and carbon nanoparticles, have been investigated for their potential in drug delivery systems. Meanwhile, sulfur, with its abundant chemically diverse organic and inorganic compounds exhibiting a range of biological functions from antioxidant properties to antibacterial and anticancer capabilities, has garnered significant attention.
Sulphur nanoparticles (SNPs) find widespread application in diverse fields such as lithium sulfur batteries, sulphur-based photocatalysts, and antimicrobial agents. Despite their extensive utilization in non-biomedical domains, such as drug delivery and cancer prevention strategies, SNPs face challenges when employed for biomedical purposes. Concerns include toxicity, limited reactivity, and the substantial particle size of SNPs, which hinder their effectiveness as drug delivery carriers. To overcome these obstacles, surface modifications of SNPs are necessary to enhance their biomedical applicability.
-
-
-
Luminescent and Scintillation Properties of LiLu(PO3)4:Pr3+ Nanophosphor
Available online: 03 December 2024More LessBackgroundRecent advancements in luminescent materials have drawn significant interest due to their wide-ranging applications in radiation detection, lighting, and display technologies. Praseodymium-doped phosphates, in particular, have shown promise because of their unique luminescent and scintillation properties.
ObjectiveThis study aims to synthesize, characterize, and evaluate the luminescent and scintillation properties of praseodymium-doped polyphosphate LiLu(PO3)4, focusing on the potential applications of these materials.
MethodsLiLu(PO3)4:Pr3+ microcrystals were synthesized using the flux method, while nanocrystals were produced via the coprecipitation technique. The synthesized polyphosphates were characterized using X-ray diffraction (XRD), scanning electron microscopy (SEM), and photoluminescence (PL) spectroscopy.
ResultsLiLu(PO3)4:Pr3+ crystals were found to crystallize in the monoclinic C2/c space group with specific lattice parameters. The structural analysis revealed that the basic units are helical ribbons of (PO3)n formed by corner-sharing PO4 tetrahedra, with LuO8 dodecahedra and LiO4 tetrahedra forming linear chains. The incorporation of praseodymium ions resulted in the observation of both ultraviolet and visible luminescence under X-ray and laser excitations. UV emission, originating from 4f-5d → 4f2 transitions, exhibited a very fast lifetime (τ4f-5d = 3 ns), while visible emission from transitions within the Pr3+ 4f2 ground configuration showed a short decay time of approximately 100 ns.
ConclusionThe scintillation properties of LiLu(PO3)4:Pr3+ demonstrated promising results, indicating their potential for various high-performance applications, including solid-state lighting, bioimaging, and radiation detection.
-
-
-
Nanomedicine Innovations for Diabetes Management: Revolutionizing Diagnosis, Treatment, and Monitoring
Authors: Shatrudhan Prajapati and Shikha YadavAvailable online: 29 October 2024More LessDiabetes mellitus, a widespread metabolic disease characterized by high blood sugar levels, affects many people globally. The limitations of conventional diagnostic and therapeutic approaches necessitate exploring innovative strategies. Nanotechnology shows remarkable potential for revolutionizing the field of diabetes theranostics (combined diagnosis and treatment) by enabling accurate diagnosis and precise treatment delivery. This article provides a comprehensive review of the latest advancements in nanomaterials for diagnosing and treating diabetes. It explores the applications of various nanomaterials, including inorganic and organic nanoparticles, nanocomposites, and nanostructured biosensors, in biomarker detection, glucose monitoring, insulin delivery, and addressing diabetes-related complications. The study focuses on the synthesis and functionalization of nanomaterials for diabetes, covering both traditional and environmentally friendly synthesis methods. This study looks into how nanomaterials can be used to carry natural antidiabetic extracts, recombinant insulin, and other antidiabetic drugs, to make them more bioavailable, targetable, and effective. However, the review also talks about the problems that come with using nanosensors to diagnose diabetes. It also looks at the newest developments in nanosensors for biomarker detection, implantable devices, and continuous glucose monitoring. Additionally, the review examines the potential of nanomaterials in the management of diabetic sequelae, including diabetic nephropathy, cardiovascular disorders, retinopathy, and wound healing. We underscore the significance of nanomaterials in islet transplantation, as they provide immunological protection and enhance the viability and efficacy of islets. This study provides useful insights into the prospects and challenges connected with the rapidly growing field of nanotechnology in diabetic theranostics through a comprehensive examination of the current landscape. Academics, clinicians, and stakeholders engaged in developing innovative nanomaterial-based approaches to accurately diagnose and effectively manage diabetes will find this resource highly helpful.
-
-
-
Cutting Edge Nanoplatforms with Smart Bio-sensing Applications: Paving the Way for Sustainable Green Approaches
Available online: 15 October 2024More LessIn the era of automation, sustainable technologies employing eco-friendly materials and manufacturing techniques such as ‘Green nanobiosensors’ have taken centre stage, owing to their opulent portfolio encompassing renewable fabrication and design from biomaterials, biocompatibility, and ease of functionalization. Generally, sensors utilize nanomaterials sourced from renewable resources or with minimal environmental impact, such as cellulose nanocrystals, chitosan, and biopolymers, owing to their exceptional properties such as high surface area.
With the advent of environmentally conscious attributes in the cutting-edge nano biosensing technology, green nano-biosensors offer innovative avenues for sensitive and selective detection and monitoring of myriad analytes with minimal environmental repercussions. Further, such sensors operate at low energy levels, contributing to reduced energy consumption, and can be mass-produced with minimal environmental influence.
The present outlay of literature aims to decipher the utilization of eco-friendly materials and sustainable manufacturing techniques in creating nano-biosensors and subsequently promulgating their advantages in terms of energy efficiency, low environmental impact, and use of renewable resources. Furthermore, this study embellishes a comprehensive framework that delineates the diverse applications of these green nanobiosensors as eco-friendly technological solutions across diverse sectors primarily agriculture, environmental monitoring, and biomedicine, showcasing their potential to revolutionize these domains while minimizing environmental impact.
-
-
-
Recent Insights and Clinical Status on Novel Mefenamic Acid Nanocarriers for the Treatment of Rheumatoid Arthritis
Authors: Sunayana Tyagi, Milind Sharad Pande and Mojahidul IslamAvailable online: 08 October 2024More LessJoint structure and performance can be compromised by the systemic inflammatory disorder rheumatoid arthritis, which destroys articular cartilage and erodes periarticular bone. However, due to their systemic processes, short half-lives, and poor bioavailability, the anti-inflammatory medicines and biological agents now utilized for the treatment of rheumatoid arthritis (RA) are unable to preferentially target inflamed joints. Anti-inflammatory medicines have made use of nanoparticle-mediated drug delivery methods. The role that inflammation plays in the genesis of disease has had far-reaching repercussions, including its ability to influence the development of disorders as diverse as inflammatory bowel disorder, RA, and osteoarthritis. In the treatment of RA, nanomaterials have the potential to both increase the absorption of the medication and selectively target the damaged joint tissue. Designer nanoparticles now have the ability to engage more thoroughly with their biological targets and a wider variety of diseases. These nanoparticles have a comparable size range and surface properties that can be modified. In this review, we have discussed the progress that has been made and the hurdles that remain in the use of nanomaterials in the treatment of RA, specifically in relation to mefenamic acid.
-